Increased fibrinolysis and platelet activation in elderly patient undergoing coronary bypass surgery

Anesthesia and Analgesia

Volumn 102, Issue 3, 2006, Pages 660-667

  Pleym, Hilde ^a,c   Wahba, Alexander ^a,b   Videm, Vibeke ^a,b   Åsberg, Arne ^a   Lydersen, Stian ^b   Bjella, Lise ^d   Dale, Ola ^a   Stenseth, Roar ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c St Elisabeth Department of Cardiothoracic Surgery   (Norway)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HEPARIN; NITRATE; PLASMIN INHIBITOR; PROTAMINE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GERIATRIC PATIENT; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; SURGICAL PATIENT; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 33644554181     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000196526.28277.45     Document Type: Article

References (21)

1. Avery GJ, Ley SJ, Hill JD, et al. Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome. Ann Thorac Surg 2001;71:591-6.
2. Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-7.
3. Moulton MJ, Creswell LL, Mackey ME, et al. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996;11:1037-46.
4. Karthik S, Grayson AD, McCarron EE, et al. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes and the effect of time delay. Ann Thorac Surg 2004;78:527-34.
5. Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Arch Surg 1998;133:442-7.
6. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998;26:225-35.
7. Boldt J, Hüttner I, Suttner S, et al. Changes of haemostasis in patients undergoing major abdominal surgery: is there a difference between elderly and younger patients? Br J Anaesth 2001;87:435-40.
8. Boldt J, Haisch G, Kumle B, et al. Does coagulation differ between elderly and younger patients undergoing cardiac surgery? Intensive Care Med 2002;28:466-71.
9. Boisclair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993;82:3350-7.
10. Boisclair MD, Lane DA, Philippou H, et al. Thrombin production, inactivation and expression during open heart surgery measured by assays for activating fragments including a new ELISA for prothrombin fragment F1 +2. Thromb Haemost 1993;70:253-8.
11. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery. Anesthesiology 1999;91:1122-51.
12. Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of haemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992;68:250-2.
13. Hunt BJ, Parratt RN, Segal HC, et al. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 1998;65:712-8.
14. Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990;62:241-5.
15. Tanaka K, Morimoto T, Yada I, et al. Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. Trans Am Soc Artif Intern Organs 1987;33:505-9.
16. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997;85:1258-67.
17. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacologic strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
18. Wahba A, Videm V. Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge. Eur J Cardiothorac Surg 2003;23:1046-50.
19. Wahba A, Black G, Koksch M, et al. Cardiopulmonary bypass leads to a preferential loss of activated platelets. Eur J Cardiothorac Surg 1996;10:768-73.
20. Wahba A, Rothe C, Lodes H, et al. Predictors of blood loss after coronary artery bypass grafting. J Cardiothorac Vasc Anest 1997;11:824-7.
21. Lemmer JH, Dilling EW, Morton JR, et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 1996;62:1659-68.